Kartik Vittala

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

Winner of best slide title at @DAVAOnc Bermuda by my Seattle colleague @KrishPatelMD 🤣

How can we re-use old drugs in lymphoma #lymsm after CAR-T failure?

In a word, जुगाड़ …

In a phrase, the same way we can combine old foods in the fridge creatively to make something new!

[Sandip Patel MD FASCO @PatelOncology]

Phenomenal bench to bedside talk on NRG1 fusions by @StephenVLiu showing importance of RNAseq in detecting this pan tumor oncogenic target @OMIonc

[Edgardo S. Santos, M.D., FACP, FASCO @edgardo_ny]

Great session on T-cell exhaustion having many experts on the panel, Drs. Ramalingam, Borghaei, Gray, and others. This is critical to understand immunotherapy and how to make it better. @OMIonc @RamalingamMD @JhanelleGray @HosseinBorghaei @GenesisCareUS @FAUMedSchool @FLASCO_ORG

[DAVA Oncology-OMI @OMIonc]

Wrapping up fantastic neoadjuvant/adjuvant discussions in the morning session - amazing slides by @LindaMThoracic and @HwakeleeMD! Stay tuned for our session on EGFR coming up next. #DAVAHawaiiLung

[Kartik Vittala @Ktrix89]

@ADesaiMD @COlazagasti @OMIonc @SylvesterCancer @StephenVLiu @NagashreeSeeth1 @LealTiciana @HosseinBorghaei @HwakeleeMD @DrRoyHerbstYale Here is the link !
https://t.co/Dy3aZIe3m0

[Coral Olazagasti, MD @COlazagasti]

A true honor to join these big leaders, physician scientists, and lung cancer expert as faculty at the upcoming Hawaii Lung Cancer Summit

@OMIonc @SylvesterCancer

[Coral Olazagasti, MD @COlazagasti]

Dr. Linda Martin highlights the pros and cons of neoadjuvant therapy in LC from a surgeon’s perspective

#HawaiiLungSummit @OMIonc

[Sandip Patel MD FASCO @PatelOncology]

Great talk about functional categorization of EGFR mutations by #johnheymach @OMIonc classifying mutations with functional perturbance to identify novel treatment strategies

[DAVA Oncology-OMI @OMIonc]

Aloha! Day 1 on our #DAVAHawaiiLung is kickstarting with our Keynote Presentations. Excited to listen and learn!

[DAVA Oncology-OMI @OMIonc]

DAVA Oncology and our esteemed Chairs welcome our faculty, fellows, and industry supporters to our 2022 Hawaii Lung Summit. Get ready for our lineup of amazing talks and debate topics as we kick-off the Summit! #DAVAHawaiiLung

[Toby Eyre @tobyeyre82]

A big new challenge in #CLL

Covalent BTKi and BCL2i exposed / resistant #CLL pts

Check out how 215 pts are managed and survival in this setting in this #EHA2022 poster with @anthonymatomd

Median OS 14.1 months in those who discontinued a covBTKi and BCL2i

[Protagonist Therapeutics @ProtagonistTx]

We're excited to participate in this year's European Hematology Association (@EHA_Hematology) Congress alongside our peers and experts in hematology.

See our data from the REVIVE Study in patients with polycythemia vera (PV) in our abstract P1028. #EHA2022

[Connie Batlevi @DrConnieBatlevi]

@OMIonc Amazing meeting! Agree with @ckitko the dialogues debates discussions are the best part! #DAVAWhistler2022 slayed it ❤️❤️❤️ Lovely to see old and new friends! @MelodySmithMD @LNastoupilMD @lymphomaphilia @mshadman @KrishPatelMD +many others

[Connie Batlevi @DrConnieBatlevi]

Solutions for CART access include NK and CAR NK tx in NHL @LNastoupilMD very little gr3+ tox. Some future trials with clear flaws, not allowing prior CD19+ tx @OMIonc #DAVAWhistler2022